MannKind Corporation (MNKD) — Stock Score Summary

MannKind Corporation (MNKD) has a MoatMap StockRank of 33/100 based on Quality (48/100), Value (41/100), and Momentum (31/100) factor scores. The current signal is SELL. MannKind Corporation relies heavily on its inhaled insulin product, Afrezza, which has struggled to gain significant market share against established injectable alternatives. It lacks a broad pipeline or the scale economics of a high-quality pharma compounder.

MannKind Corporation is a biopharmaceutical company developing and commercializing inhaled therapeutic products, primarily for endocrine and orphan lung diseases, including Afrezza, an inhaled insulin. It possesses a proprietary Technosphere® drug delivery platform, enabling rapid absorption of therapeutic proteins and peptides via inhalation. MannKind is a niche player leveraging unique drug delivery technology to address unmet medical needs.

Key Financial Metrics

Price$3.57
Market Cap$1.1B
P/E (Forward)18.29
Price/Book-18.33
Return on Invested Capital6.3%
Gross Margin75.6%
Operating Margin-3.3%
Revenue Growth15.1%
Free Cash Flow$47M

MannKind Corporation operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is MannKind Corporation’s (MNKD) StockRank?
MoatMap’s StockRank for MannKind Corporation (MNKD) is 33/100, with a Sell signal. It is a composite of Quality (48), Value (41), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does MannKind Corporation have an economic moat?
MannKind Corporation (MNKD) has a Quality factor score of 48/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is MannKind Corporation a buy, hold, or sell?
MoatMap’s current signal for MannKind Corporation (MNKD) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is MannKind Corporation in?
MannKind Corporation (MNKD) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksMNKD deep dive reportAI ChampionsHow we score stocksSense-check another stock